MK
Manjula Kalia
Regional Centre for Biotechnology, Translational Health Science & Technology Institute, National Institute of Immunology
0000-0002-3376-3659
Employment
-
Regional Centre for Biotechnology Professor2024 - Present
-
Regional Centre for Biotechnology Associate Professor2018 - 2024
-
Translational Health Science & Technology Institute Research Scientist E2015 - 2018
-
Translational Health Science & Technology Institute Research Scientist D2010 - 2015
Education
-
National Institute of Immunology PhD1993 - 1998
Projects & Funding
Projects & funding information is unavailable.
Publications (55)
- STING is a key driver of Japanese encephalitis virus induced inflammatory response Save
- Trifluoperazine exhibits broad-spectrum antiviral activity against arboviruses Save
- Downmodulation of cholesterol biosynthetic network governs activation of the innate immune response to Japanese encephalitis virus infection Save
- AGPAT1 is a novel Chikungunya virus receptor on human cells Save
- Endophilin mediated endocytosis and epidermal growth factor receptor govern Japanese encephalitis virus entry and infection in neuronal cells. Save
- STING is a key driver of Japanese encephalitis virus induced inflammatory response Save
- AGPAT1 is a novel Chikungunya virus receptor on human cells Save
- Role of RNA G-Quadruplexes in the Japanese Encephalitis Virus Genome and Their Recognition as Prospective Antiviral Targets. Save
- Japanese encephalitis virus hijacks ER-associated degradation regulators for its replication Save
- SARS-CoV-2 infection induces thymic atrophy mediated by IFN-γ in hACE2 transgenic mice. Save